Chinese artificial intelligence start-up StepFun has appointed Yin Qi, the co-founder and former CEO of Megvii, as its chairman, as the company wraps up a 5 billion yuan (US$690 million) Series B+ fun...
Read more
Pony Ma Huateng, founder and CEO of Chinese tech giant Tencent Holdings, has teased a new artificial intelligence-powered social feature in the company’s latest push to keep pace in China’s intensifyi...
Read more
China’s Eyou Robot Technology has launched the world’s first automated production line for robot joints, positioning itself to capture growth ahead of a projected surge in humanoid robot shipments. Th...
Read more
Jensen Huang marked the coming Lunar New Year with Nvidia employees in Shanghai on Saturday, as the CEO of the world’s most valuable company made his first trip to China in 2026 amid uncertainties aro...
Read more
The plans of Alibaba Group Holding and Baidu to list their semiconductor design units could intensify competition with other domestic artificial intelligence chip developers to unseat Nvidia as the co...
Read more
Zhipu AI, known internationally as Z.ai, is restricting sign-ups for its new flagship artificial intelligence coding product, as existing users face performance issues amid a computing crunch that con...
Read more
Moore Threads, one of China’s artificial intelligence chip champions, expects to report a tripling of revenue for 2025, reflecting how local semiconductor firms are expanding rapidly amid Beijing’s pu...
Read more
Chinese AI companies wanting high-performance artificial intelligence chips from Nvidia are facing a dilemma: source them from the black market at much higher prices, or accept lower performance domes...
Read more
Significant worldwide shortages of memory chips are expected to persist well into 2027, according to analysts, even as the sector’s top manufacturers – Samsung Electronics, SK Hynix and Micron Technol...
Read more
Shanghai-based Harbour BioMed’s acquisition of a stake in US-based Spruce Biosciences is the latest example of China’s novel drug developers progressing from one-time licensing deals into long-lasting...
Read more